So Cavatak nearly doubles the effectiveness of Keytruda, which had revenues of $1.4 billion last year alone. What does that make Cavatak worth?
Ann: Promising Results CAPRA Melanoma Trial expand to 50 patients, page-2
Add to My Watchlist
What is My Watchlist?